Fbxo10em1Ccg
Endonuclease-mediated Allele Detail
|
Symbol: |
Fbxo10em1Ccg |
Name: |
F-box protein 10; endonuclease-mediated mutation 1, Christopher C Goodnow |
MGI ID: |
MGI:6721013 |
Synonyms: |
Fbxo10E54K |
Gene: |
Fbxo10 Location: Chr4:45034248-45084555 bp, - strand Genetic Position: Chr4, 23.68 cM
|
Alliance: |
Fbxo10em1Ccg page
|
|
|
Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
Mutation: |
|
Single point mutation
|
|
|
Mutation details: CRISPR/Cas9 technology generated a GAG>AAG mutation in exon 2 resulting in a glutamate to lysine substitution at amino acid 54 (p.E54K). This is a very rare, predicted damaging, missense variant identified in a child with multiple autoimmune disease and possible learning difficulties. This variant has also been found as a heterozygous de novo mutation in a child with autism spectrum disorder.
(J:307413)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Fbxo10 Mutation: |
49 strains or lines available
|
|
Original: |
J:307413 Masle-Farquhar E, et al., Loss-of-function of Fbxo10, encoding a post-translational regulator of BCL2 in lymphomas, has no discernible effect on BCL2 or B lymphocyte accumulation in mice. PLoS One. 2021;16(4):e0237830 |
All: |
1 reference(s) |
|